Patents by Inventor Eduardo Maffud Cilli

Eduardo Maffud Cilli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210132050
    Abstract: The present application relates to an electrode suitable for use in electrochemical sensing of a target species. The electrode comprises a peptide monolayer of defined length and to one end of which are attached both a redox active species and a receptor that is capable of binding to the target species. Also provided is an electrochemical method of sensing a target species, which involves the use of the electrode.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 6, 2021
    Applicants: Oxford University Innovation Limited, Universidade Estadual Paulista "Júlio De Mesquita Filho' - UNESP
    Inventors: Eduardo Maffud Cilli, Paulo Roberto Bueno
  • Patent number: 7193039
    Abstract: The present invention refers to the chemical synthesis and potentiality for application in several biochemical assays, of a potent agonist of the ?-melanocyte stimulating hormone (?-MSH), labeled with an amino acid-type paramagnetic spin probe (Toac, or 2,2,6,6-tetramethylpiperidine-1-oxyl-amino-4-carboxylic acid), valuable for use in electron spin resonance and fluorescence allowing biochemical-clinical investigation of relevant physiological roles of ?-MSH in animal organism. The referred analogue of the present invention, acetil-Toac0-(Nle4, DPhe7)-?-MSH, where (Nle4, DPhe7)-?-MSH is nominated commercially as Melanotan™ and although containing a non-natural compound in its structure such as Toac, maintained entirely its potent agonist potency.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: March 20, 2007
    Assignee: Conselho Nacional de Desenvolvimento Cientifico E Technologico-CNPQ
    Inventors: Clovis Ryuichi Nakaie, Simone Dos Reis Barbosa, Eduardo Maffud Cilli, Maria Tereza Lamy-Freund, Armando Siuiti Ito, Maria Aparecida Visconti, Ana Maria De Lauro Castrucci
  • Publication number: 20030212254
    Abstract: The present invention refers to the discovery that the anion exchange resin DEAE-Sephadex A50™ might be also used alternatively as polymeric support for peptide synthesis and affinity chromatography. It was possible to synthesize a model octapeptide (angiotensin II) in this resin using the Fmoc-chemistry and when appropriate “linker groups” are used, free peptide cleaved from the resin can be obtained containing C-terminal extremity in carboxylate or carboxamide forms. By considering the feasibility of synthesizing peptide sequence throughout its structure, the repetitive (NANP)3 sequence found in the antigenic epitope of the sporozoite form of Plasmodium falciparum involved in the malaria transmission was assembled in the DEAE-Sephadex A50 resin. Column with the synthesized (NANP)3-containing DEAE-Sephadex A50 resin retained quantitatively antibody for (NANP)3 sequence which was further removed through usual washing process, thus demonstrating the feasibility of using this anion.
    Type: Application
    Filed: October 23, 2002
    Publication date: November 13, 2003
    Inventors: Clovis Ryuichi Nakaie, Danielle Alvez Ianzer, Eduardo Maffud Cilli, Mauricio Martins Rodrigues
  • Publication number: 20030212251
    Abstract: The present invention refers to the chemical synthesis and potentiality for application in several biochemical assays, of a potent agonist of the &agr;-melanocyte stimulating hormone (&agr;-MSH), labeled with an amino acid-type paramagnetic spin probe (Toac, or 2,2,6,6-tetramethylpiperidine-1-oxyl-amino-4-carboxylic acid), valuable for use in electron spin resonance and fluorescence allowing biochemical-clinical investigation of relevant physiological roles of &agr;-MSH in animal organism. The referred analogue of the present invention, acetil-Toac0-(Nle4, DPhe7)-&agr;-MSH, where (Nle4, DPhe7)-&agr;-(MSH is nominated commercially as Melanotan™ and although containing a non-natural compound in its structure such as Toac, maintained entirely its potent agonist potency.
    Type: Application
    Filed: October 28, 2002
    Publication date: November 13, 2003
    Inventors: Clovis Ryuichi Nakaie, Simone Dos Reis Barbosa, Eduardo Maffud Cilli, Maria Teresa Lamy-Freund, Armando Siuiti Ito, Maria Aparecida Visconti, Ana Maria De Lauro Castrucci
  • Patent number: 6582968
    Abstract: The present invention relates to an &agr;-melanocyte stimulating hormone (&agr;-MSH) analogue, labeled with an amino acid-type paramagnetic spin probe, for example, Toac, or 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, and methods for the synthesis thereof. The preferred analogue of the invention, acetyl-Toac0-&agr;-MSH (abbreviated as EPM-2) is the first such analogue that maintains entirely the natural &agr;-MSH activity.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: June 24, 2003
    Assignee: Conselho Nacional de Desenvolvimento Cientifico e Technologico PROJUR/CNPq/AC
    Inventors: Clóvis Ryuichi Nakaie, Eduardo Maffud Cilli, Maria Tereza Lamy-Freund, Simone dos Reis Barbosa
  • Publication number: 20020137682
    Abstract: The present invention relates to a &agr;-melanocyte stimulating hormone (&agr;-MSH) analogue, labeled with an amino acid-type paramagnetic spin probe, for example, Toac, or 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, and methods for the synthesis thereof The preferred analogue of the invention, acetyl-Toac0-&agr;-MSH (abbreviated as EPM-2) is the first such analogue that maintains entirely the natural &agr;-MSH activity.
    Type: Application
    Filed: August 24, 2001
    Publication date: September 26, 2002
    Inventors: Clovis Ryuichi Nakaie, Eduardo Maffud Cilli, Maria Tereza Lamy-Freund, Simone dos Reis Barbosa